Taking 300 mg of aspirin may prevent occlusion of bypasses more effectively than 150 mg or less. Lim and colleagues (p 1309) conducted an indirect comparison meta-analysis on 3281 patients taking low (< 150 mg) or medium (300-325 mg) doses of aspirin in the year after surgery. All patients were studied by coronary angiography. Although the difference was not statistically significant, there was a trend towards better graft patency (risk ratio 0.74) and reduced coronary events (risk ratio 0.81) with medium dosage, and this may be the optimum dose in the first year.
